Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 72722 record(s)

Req # A-2019-001849

Adverse Reaction Report (AER). Report number: E2B_02733268.

Organization: Health Canada

38 page(s)
April 2020

Req # A-2019-001904

Adverse Reaction Report (AER) for LEFLUNOMIDE. Report numbers: E2B_02406362, E2B_02430073, E2B_02406722, E2B_02406957, E2B_02407828, E2B_02407902, E2B_02410099, E2B_01578688, E2B_02421206, E2B_02422361, E2B_02421091, E2B_02421097, E2B_02401716,…

Organization: Health Canada

466 page(s)
April 2020

Req # A-2019-001908

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 19-123505-887, PATCHING UPDATE.

Organization: Health Canada

7 page(s)
April 2020

Req # A-2019-001919

Adverse Reaction Report (AER). Report numbers: 000116945, 000143149, 000226965, 000301725, 000704548.

Organization: Health Canada

82 page(s)
April 2020

Req # A-2019-001929

Adverse Reaction Report (AER) for Immunoglobulin (human). Report numbers: 000730767, E2B_02825746, E2B_02833294, E2B_02843902, E2B_02855863, E2B_02865514.

Organization: Health Canada

216 page(s)
April 2020

Req # A-2019-001976

Adverse Reaction Report (AER). Report number: E2B_02808720.

Organization: Health Canada

8 page(s)
April 2020

Req # A-2019-001977

Adverse Reaction Report (AER). Report number: E2B_02812066.

Organization: Health Canada

10 page(s)
April 2020

Req # A-2019-001980

Adverse Reaction Report (AER). Report number: E2B_02808729.

Organization: Health Canada

7 page(s)
April 2020

Req # A-2019-001985

Adverse Reaction Report (AER). Report number: 000728760.

Organization: Health Canada

1 page(s)
April 2020

Req # A-2019-001987

Adverse Reaction Report (AER). Report number: E2B_02745395.

Organization: Health Canada

7 page(s)
April 2020
Date modified: